RAMM Pharma Corp.
RAMM
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.67% | 47.54% | 88.58% | 57.61% | -196.40% |
| Total Depreciation and Amortization | -58.12% | -50.92% | -31.58% | -26.44% | 22.98% |
| Total Amortization of Deferred Charges | -42.86% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.11% | 95.49% | -733.69% | -102.71% | 284.00% |
| Change in Net Operating Assets | 16.75% | 144.93% | -35.63% | 4,346.67% | 3,116.35% |
| Cash from Operations | 86.41% | 79.34% | 56.25% | 79.31% | 54.42% |
| Capital Expenditure | -- | -- | 17,700.00% | -83.33% | 58.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -122.94% |
| Cash from Investing | 1,384.76% | 349.66% | 1,957.61% | -154.66% | -124.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 80.07% | 70.74% | 16.41% | -11.90% | 7.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -101.63% | 2.38% | -- | -- | -25.68% |
| Cash from Financing | 71.65% | 62.35% | 37.55% | -6.24% | -4.43% |
| Foreign Exchange rate Adjustments | -38.89% | -158.33% | -396.83% | 206.00% | -91.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.89% | 82.62% | 122.06% | 74.09% | 44.15% |